Leerink Partners Begins Coverage on CorMedix (NASDAQ:CRMD)
Stock analysts at Leerink Partners started coverage on shares of CorMedix (NASDAQ:CRMD – Get Free Report) in a report released on Friday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $18.00 price target on the stock. Leerink Partners’ price target points to a potential upside of 68.07% from the stock’s current price. A […]
Stock analysts at Leerink Partners started coverage on shares of CorMedix (NASDAQ:CRMD – Get Free Report) in a report released on Friday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $18.00 price target on the stock. Leerink Partners’ price target points to a potential upside of 68.07% from the stock’s current price. A […]
